Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Trevi Therapeutics, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Trevi Therapeutics stockholders approved amendments to the 2019 Stock Incentive Plan on June 3, 2026, increasing available shares by 8 million and implementing stricter compensation controls to align pay with performance and reduce shareholder dilution.
Key Takeaways
8,000,000 additional shares authorized for issuance under the amended 2019 Stock Incentive Plan
Non-employee director compensation has been limited to control costs and align with governance best practices
1 more takeaway